We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KR icon
251
Kroger
KR
$34.8B
$14.1M 0.1%
196,000
+40,500
+26% +$2.8M
MRSH
252
Marsh
MRSH
$86.3B
$14M 0.1%
63,900
-1,000
-2% -$226K
BMY icon
253
Bristol-Myers Squibb
BMY
$127B
$13.9M 0.1%
301,350
-17,200
-5% -$844K
CHD icon
254
Church & Dwight Co
CHD
$23.1B
$13.9M 0.1%
144,900
-2,000
-1% -$197K
GMED icon
255
Globus Medical
GMED
$10.4B
$13.9M 0.1%
235,600
+900
+0.4% +$58.1K
PFE icon
256
Pfizer
PFE
$140B
$13.9M 0.1%
573,500
-467,425
-45% -$10.9M
OGS icon
257
ONE Gas
OGS
$5.05B
$13.7M 0.1%
190,800
– –
PSX icon
258
Phillips 66
PSX
$82.9B
$13.7M 0.1%
114,850
+625
+0.5% +$70K
SJM icon
259
J.M. Smucker
SJM
$12.6B
$13.7M 0.1%
139,150
-3,100
-2% -$341K
WBA
260
DELISTED
Walgreens Boots Alliance
WBA
$13.5M 0.1%
1,179,100
+737,050
+167% +$8.21M
NOC icon
261
Northrop Grumman
NOC
$77B
$13.4M 0.1%
26,867
– –
CHDN icon
262
Churchill Downs
CHDN
$6.03B
$13.4M 0.1%
132,800
-400
-0.3% -$39.2K
TNC icon
263
Tennant Co
TNC
$1.5B
$13.4M 0.1%
172,987
+4,887
+3% +$361K
EPC icon
264
Edgewell Personal Care
EPC
$1.27B
$13.4M 0.09%
570,925
-136,500
-19% -$3.78M
PG icon
265
Procter & Gamble
PG
$343B
$13.4M 0.09%
83,855
-4,339
-5% -$708K
AMAT icon
266
Applied Materials
AMAT
$426B
$13.2M 0.09%
72,222
-80
-0.1% -$12.7K
CMS icon
267
CMS Energy
CMS
$23.1B
$13.2M 0.09%
190,217
– –
CXT icon
268
Crane NXT
CXT
$3.04B
$13M 0.09%
241,589
+104,339
+76% +$5.31M
LBTYA icon
269
Liberty Global Class A
LBTYA
$3.31B
$12.9M 0.09%
1,290,295
-24,500
-2% -$246K
TTWO icon
270
Take-Two Interactive
TTWO
$43B
$12.9M 0.09%
53,025
+520
+1% +$117K
BAC icon
271
Bank of America
BAC
$435B
$12.8M 0.09%
271,100
-79,630
-23% -$3.35M
SMP icon
272
Standard Motor Products
SMP
$861M
$12.8M 0.09%
415,104
+91,104
+28% +$2.52M
ACA icon
273
Arcosa
ACA
$7.12B
$12.7M 0.09%
145,934
-1,857
-1% -$155K
FLO icon
274
Flowers Foods
FLO
$1.64B
$12.5M 0.09%
783,954
-15,000
-2% -$259K
KHC icon
275
Kraft Heinz
KHC
$30.4B
$12.5M 0.09%
484,800
-37,300
-7% -$1.04M
9 10
11
12 13

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.